USE OF P38 INHIBITORS FOR THE TREATMENT OF SMOKE INHALATION
摘要
<p>The present invention is directed to the novel use of a CSBP/p38 inhibitor for the treatment, including prophylaxis of smoke induced pathology resulting from acute and chronic inflammation in the lung.</p>
